JP Morgan Week 2026About this Event
Over the past decade, China's innovative drug pipeline has experienced explosive growth, becoming an integral part of the global pharmaceutical landscape. In 2025, the total value of cross-border licensing for Chinese innovative drugs surpassed $100 billion, doubling the scale of the previous year. Despite this progress, only about 10% of China's new drug pipelines have been involved in transactions, leaving immense untapped potential for collaboration.
To bridge this gap, the Zhongguancun FIC Innovative Drug Strategic Development Alliance(ZFIC Alliance) is proud to host 2026 China FIC Innovation & Collaboration Summit during the 2026 JPM Conference. This summit aims to create an efficient communication platform for international5 pharmaceutical companies,investment institutions, and Chinese biotech enterprises.
You can visit our offical website for detail information οΌhttps://www.ficpharma.org/?lang=en
Agenda
π: 08:30 AM - 09:00 AM
Free Networking
Info: Registration
π: 09:00 AM - 09:20 AM
Opening Remarks
π: 09:20 AM - 09:50 AM
10 Years of Development of China's Innovative Drugs
Info: Keynote Speech
π: 09:50 AM - 10:10 AM
Trends in China's Biotech Innovation
Info: Keynote Speech
π: 10:10 AM - 10:20 AM
Coffee Break
π: 10:20 AM - 10:40 AM
Trends and Data Insights of China's Innovative Drug Out-Licensing Transactions
Info: Keynote Speech
π: 10:40 AM - 11:00 AM
Highlights of Chinaβs innovation in Oligonucleotide Innovative Drugs
Info: Keynote Speech
π: 11:00 AM - 12:00 PM
Outlook of China's FIC Pipeline
Info: Panel Discussion
π: 12:15 PM - 01:30 PM
Buffet Lunch
π: 01:30 PM - 02:00 PM
Mining China's FIC Innovative Drugs
Info: Keynote Speech
π: 02:00 PM - 04:00 PM
Roadshow
π: 04:00 PM
How to Identify the Next "Blockbuster" among FIC Drugs
Info: Panel Discussion
π: 05:00 PM - 06:00 PM
Beijing's Innovative Drug R&D Ecosystem
Info: Panel Discussion
π: 06:00 PM
Event Closure
Event Venue
Hyatt Regency San Francisco Downtown SOMA, 50 3rd Street, San Francisco, United States
USD 0.00
